An official website of the United States government
Value Set and Code System Information
| Code System Name | NullFlavor |
| Value Set Code | PHVS_SyphilisClinicalStage_CS |
| Value Set Name | Syphilis Clinical Stage (CS) |
| Value Set Version | 1 |
Value Set Concept Details
| Concept Code | UNK |
| Preferred Concept Name | unknown |
| Value Set Concept Status | Published |
| Value Set Concept Status Date | 09/15/2014 |
| Value Set Concept Description | |
| Sequence | 7 |
Code System Concept Details
| Code System Concept Name | unknown |
| Code System Concept Status | Published |
| Code System Preferred Concept Name | unknown |
| Date Created | |
| Date Revised | 05/01/2009 |
Associated Value Sets
| Value Set Name | Version(s) | |
|---|---|---|
| Abnormal Chest X-Ray Finding (TB) | 1 | |
| Abnormal Chest X-ray Condition Status | 1 | |
| Activity Type (Brucellosis) | 2 , 1 | |
| Activity Type (Leptospirosis) | 1 | |
| Activity Type Anthrax | 1 | |
| Actual Route of Administration (Anthrax) | 1 | |
| Acute Convalescent IgG Difference (VPD) | 1 | |
| Age Group (Flu) | 1 | |
| Age Unit (NETSS) | 2 , 1 | |
| Age Unit (NND) | 1 | |
| Age Unit (Syndromic Surveillance) | 1 | |
| Age unit | 2 , 1 | |
| Alanine aminotransferase (ALT) Result (Hepatitis) | 2 , 1 | |
| Animal Exposure Location (Brucellosis) | 1 | |
| Animal Ownership (Brucellosis) | 2 , 1 | |
| Animal Species (Animal Rabies) | 1 | |
| Animal Type (Anthrax) | 1 | |
| Animal Type (Brucellosis) | 1 | |
| Animal Type (COVID-19) | 1 | |
| Animal Type (FDD) | 3 , 2 , 1 | |
| Animal Type (Leptospirosis) | 2 , 1 | |
| Antacids (FDD) | 1 | |
| Antibiotic Dose Units (Brucellosis) | 3 , 2 , 1 | |
| Antibiotic Reason (RIBD) | 1 | |
| Antibiotic Received (Pertussis) | 5 , 4 , 3 , 2 , 1 | |
| Antibiotic Received (RIBD) | 2 , 1 | |
| Antibiotic Treatment (NETSS) | 1 | |
| Antibiotics (FDD) | 5 , 4 , 3 , 2 , 1 | |
| Antimicrobials (Anthrax) | 1 | |
| Assisted Living Exposure Type (RIBD) | 1 | |
| Bacterial Infection Syndrome (IPD) | 1 | |
| Bird Type (RIBD) | 1 | |
| Birth Attendant Titles (NCHS) | 3 | |
| Birth Attendees (VPD) | 1 | |
| Birth Country | 7 , 6 , 5 , 4 , 3 , 2 | |
| Birth Location (Listeria) | 1 | |
| Birth Location (RIBD) | 1 | |
| Birth Location (VPD) | 1 | |
| Birth Outcome (Rubella) | 2 , 1 | |
| Birth Outcome (VPD) | 1 | |
| Birth Status (NND) | 1 | |
| Birth or Delivery Occurred (NCHS) | 2 | |
| Blood Contact Frequency (Hepatitis) | 1 | |
| Blood Product | 1 | |
| Body Region(s) of Rash | 2 , 1 | |
| Brucella Exposure (Brucellosis) | 2 , 1 | |
| CSF WBC Protein Result (NND) | 1 | |
| Campylobacter Nonculture Test Type (BIDS) | 1 | |
| Case Class Status (NETSS) | 1 | |
| Case Classification Exposure Source | 2 , 1 | |
| Case Classification Status | 1 | |
| Case Detection Method | 3 , 2 | |
| Case Investigation Status | 3 , 2 | |
| Case Traced to Carrier | 1 | |
| Case Transmission Mode (BIDS) | 1 | |
| Case Type (CP-CRE) | 1 | |
| Cause of Death Related to TB | 1 | |
| Character of Lesions | 2 , 1 | |
| Chest XRay Result | 1 | |
| Clinical Finding (COVID-19) | 1 | |
| Clinical Manifestations (Anthrax) | 1 | |
| Clinical Manifestations (Brucellosis) | 1 | |
| Clinical Manifestations (Leptospirosis) | 2 , 1 | |
| Clinical Manifestations (STD) | 1 | |
| Clinical Outcome (Anthrax) | 1 | |
| Clinical Syndrome (Arbovirus) | 7 , 6 , 5 , 4 , 3 , 2 , 1 | |
| Clinician Observed Lesions (STD) | 1 | |
| College Living Situation (RIBD) | 2 , 1 | |
| Colony Count Magnitude | 2 , 1 | |
| Common-Source Outbreak (Hepatitis A) | 1 | |
| Complications (Mumps) | 7 , 6 , 5 | |
| Condition Status (FDD) | 2 , 1 | |
| Contact Type (Anthrax) | 1 | |
| Contact Type (Brucellosis) | 1 | |
| Contact Type (COVID-19) | 1 | |
| Contact Type (Hepatitis A) | 1 | |
| Contact Type (Hepatitis B and C) | 1 | |
| Contact Type (RIBD) | 1 | |
| Contact Type Hepatitis A (NETSS) | 1 | |
| Contributory Tobacco Use (NCHS) | 3 , 2 | |
| Country | 6 , 5 , 4 , 3 | |
| Country of Product Acquisition (Brucellosis) | 2 , 1 | |
| County | 3 , 2 | |
| Critical Infrastructure Sector (NND) | 1 | |
| Cruise Line (RIBD) | 1 | |
| Current Sex (NND) | 1 | |
| Darkfield DFA Result (CS) | 1 | |
| Data Reporting Source (CO) | 2 , 1 | |
| Data Reporting Source (COVID-19) | 1 | |
| Day Care Setting (FDD) | 1 | |
| Decedent Education Level (NCHS) | 1 | |
| Definitely Possibly No (RIBD) | 2 , 1 | |
| Delivery Routes (NCHS) | 2 | |
| Delivery Type (RIBD) | 1 | |
| Detection Method (COVID-19) | 2 , 1 | |
| Detection Method (STD) | 2 | |
| Diabetes Status | 1 | |
| Diagnosed Pneumonia By (VZ) | 1 | |
| Diagnosed by (VZ) | 4 , 3 , 2 | |
| Diagnostic Lab Test Findings (NND) | 1 | |
| Diagnostic Test Finding (Anthrax) | 1 | |
| Diet Type (Anthrax) | 1 | |
| Directly Observed Therapy (TB) | 1 | |
| Discharge Location (RIBD) | 3 , 2 , 1 | |
| Disease Acquired Jurisdiction | 3 , 2 , 1 | |
| Disease Acquired Jurisdiction (NETSS) | 1 | |
| Disease Outcome Type (Leptospirosis) | 2 , 1 | |
| Disease Stage (Brucellosis) | 2 , 1 | |
| Disposition OPD (NCHS) | 1 | |
| Division Vital Statistics (County) | 1 | |
| Drinking Water (FDD) | 1 | |
| Duration Unit | 2 , 1 | |
| Duration Unit (1) | 1 | |
| E. coli Shiga Toxin (BIDS) | 1 | |
| E. coli Shiga Toxin Test Type (BIDS) | 1 | |
| Emergency Department Acuity | 1 | |
| Employment Status | 1 | |
| Employment Status (Flu) | 1 | |
| Epilinked Case Type (VZ) | 5 , 4 , 3 , 2 | |
| Establishment Type (RIBD) | 1 | |
| Ethnicity (ARLN) | 1 | |
| Ethnicity Detail (NCHS) | 2 , 1 | |
| Ethnicity Group (NCHS) | 2 , 1 | |
| Ethnicity Group including Unknown | 2 , 1 | |
| Exposure Location (Brucellosis) | 1 | |
| Exposure Risk (Brucellosis) | 1 | |
| Exposure Setting (COVID-19) | 2 , 1 | |
| Exposure Setting Master (RIBD) | 1 | |
| Exposure Site Category (CO) | 4 , 3 , 2 | |
| Exposure Source (Anthrax) | 1 | |
| Exposure Source (Brucellosis) | 4 , 3 , 2 , 1 | |
| Exposure Source (CO) | 3 , 2 , 1 | |
| Exposure Type (Leptospirosis) | 1 | |
| Extended Race Group (Listeria) | 1 | |
| Extreme Weather Type (CO) | 4 , 3 , 2 , 1 | |
| Facility Type (RIBD) | 1 | |
| Fetal Death Cause or Condition (NCHS) | 1 | |
| Fetal Death Time Points (NCHS) | 1 | |
| Fetal Neonatal Infection Type (FDD) | 1 | |
| Fetal Neonatal Specimen Type | 1 | |
| Fetal Outcome (RIBD) | 2 , 1 | |
| Fetal Presentations (NCHS) | 3 | |
| Fetal Remains Disposition Method (NCHS) | 1 | |
| Final Treatment Outcome (TB) | 1 | |
| Follow-up Attempt Outcome (NCHS) | 2 , 1 | |
| Food Cooking Method (FDD) | 1 | |
| Food Cooking Method (Trich) | 1 | |
| Food Processing Method (FDD) | 1 | |
| Food Processing Method (Trich) | 1 | |
| Food Product Consumed (Brucellosis) | 2 , 1 | |
| Fresh Berries (FDD) | 2 , 1 | |
| Fresh Herbs (FDD) | 2 , 1 | |
| Fresh Produce (FDD) | 2 , 1 | |
| Fresh Water or Mud Type (Leptospirosis) | 2 , 1 | |
| GAS Risk Factor Interval (RIBD) | 1 | |
| Gender (ARLN) | 1 | |
| Gender Identity | 4 , 3 , 2 , 1 | |
| Gender Identity (NNDSS) | 1 | |
| Gender Identity (STD) | 1 | |
| General Condition Status | 1 | |
| Generator Distance (CO) | 3 , 2 | |
| Generator Location (CO) | 4 | |
| Genotype (Measles) | 1 | |
| Genotype (Rubella) | 3 , 2 , 1 | |
| Geographic Region (NETSS) | 1 | |
| Gestational Age Determination (RIBD) | 2 , 1 | |
| Glove Material (RIBD) | 1 | |
| H. influenzae Serotype (RIBD) | 1 | |
| HBV DNA Test Result (Hepatitis B Perinatal) | 3 , 2 , 1 | |
| HBeAg Test Result (Hepatitis B Perinatal) | 1 | |
| HBsAg Test Result (Hepatitis B Perinatal) | 1 | |
| HIV Diagnosis Based On | 1 | |
| HIV Status | 1 | |
| HIV Status (STD) | 4 , 3 , 2 , 1 | |
| Health Care Practice Type (TB) | 1 | |
| Healthcare Exposure Type (RIBD) | 2 , 1 | |
| Healthcare Occupation (COVID-19) | 2 , 1 | |
| Heated Food (Listeria) | 1 | |
| Hispanic Ethnic Group (Listeria) | 1 | |
| Hospital Procedure (Leptospirosis) | 2 , 1 | |
| IgM Test Type (VZ) | 1 | |
| Illness (Listeria) | 2 , 1 | |
| Immigration Status | 1 | |
| Immunization Funding Source (IIS) | 1 | |
| Immunization Information Source (CRS) | 4 , 3 , 2 | |
| Infant Anti-HCVTest Result (Hepatitis C Perinatal) | 1 | |
| Infant HCV Antigen Test Result (Hepatitis C) | 1 | |
| Infant Nucleic Acid Test Result (Hepatitis C) | 1 | |
| Infection Type (RIBD) | 1 | |
| Injury Occurred Environment (NETSS) | 1 | |
| Injury Occurred Environment (VPD) | 1 | |
| Injury Type (NETSS) | 1 | |
| Injury Type (VPD) | 1 | |
| Insurance Type (RIBD) | 1 | |
| Intent of Exposure (CO) | 1 | |
| Job Setting (COVID-19) | 1 | |
| Lab Result (Pertussis) | 1 | |
| Lab Result (Rubella) | 1 | |
| Lab Test (Hansen) | 2 | |
| Lab Test Interpretation | 2 , 1 | |
| Lab Test Interpretation (Legionellosis) | 1 | |
| Lab Test Interpretation (Pertussis) | 5 , 4 , 3 , 2 , 1 | |
| Lab Test Interpretation (RIBD) | 2 , 1 | |
| Lab Test Interpretation (TB) | 3 , 2 , 1 | |
| Lab Test Interpretation (Trich) | 1 | |
| Lab Test Interpretation (VPD) | 7 , 6 , 5 , 4 , 3 , 2 , 1 | |
| Lab Test Interpretation (Varicella) | 4 , 3 , 2 , 1 | |
| Lab Test Interpretation Master (RIBD) | 1 | |
| Lab Test Method (MDRO) | 3 , 2 , 1 | |
| Lab Test Method (RIBD) | 2 , 1 | |
| Lab Test Procedure (Malaria) | 1 | |
| Lab Test Procedure (Rubella) | 6 , 5 , 4 | |
| Lab Test Reactivity (NND) | 1 | |
| Lab Test Result (PHLIP Flu) | 14 | |
| Lab Test Result Interpretation (NND) | 2 | |
| Lab Test Result Lyme (NETSS) | 1 | |
| Lab Test Result Qualitative (NND) | 3 , 2 | |
| Lab Test Result Qualitative (Syphilis) | 1 | |
| Lab Test Type (Babesiosis) | 2 | |
| Lab Test Type (Mumps) | 6 , 5 | |
| Lab Test Type (Pertussis) | 6 , 5 | |
| Late Clinical Manifestation (STD) | 1 | |
| Legionella Exposure Setting (RIBD) | 2 , 1 | |
| Legionellosis Serogroup (RIBD) | 2 , 1 | |
| Lettuce Type (FDD) | 2 , 1 | |
| Likely Contact (Listeria) | 1 | |
| LikelyAte (Listeria) | 1 | |
| Location Type (Leptospirosis) | 2 , 1 | |
| Manufacturers Of Vaccines (NETSS) | 1 | |
| Marital Status HL7 | 1 | |
| Maternal Infection (FDD) | 1 | |
| Meat Consumed Type (Trich) | 1 | |
| Meat Purchase Info (FDD) | 1 | |
| Meat Purchase Info (Trich) | 1 | |
| Medical History (Listeria) | 1 | |
| Medication (Brucellosis) | 1 | |
| Medication (Leptospirosis) | 2 , 1 | |
| Medication Administered (Anthrax) | 1 | |
| Medication Administered (FDD) | 1 | |
| Medication Administered (Hansen) | 1 | |
| Medication Completed (Brucellosis) | 2 , 1 | |
| Medication Missed (Malaria) | 1 | |
| Medication Prophylaxis (Malaria) | 5 , 4 , 3 , 2 , 1 | |
| Medication Received (Lyme) | 3 | |
| Medication Received (TBRD) | 2 | |
| Medication Received (VZ) | 3 | |
| Medication Route (STD) | 1 | |
| Medication Treatment (Malaria) | 5 , 4 , 3 , 2 , 1 | |
| Medication Treatment (STD) | 1 | |
| Methods of Disposition (NCHS) | 2 , 1 | |
| Microorganism (RIBD) | 1 | |
| Microorganism (STD) | 1 | |
| Microscopic Exam Culture Site (TB) | 3 , 2 , 1 | |
| Mode of Delivery (RIBD) | 2 , 1 | |
| Molecular Indel (TB) | 1 | |
| Molecular Test Methods (TB) | 1 | |
| Molecular Test Results (TB) | 1 | |
| Mother Nucleic Acid Test Result (Perinatal Hep) | 1 | |
| N. meningitidis Serogroup (RIBD) | 2 , 1 | |
| Neurological Manifestation (STD) | 2 , 1 | |
| No Case Reason (CRS) | 1 | |
| Non Pork Type (FDD) | 1 | |
| Non-Sterile Specimen (Pediatric Flu) | 1 | |
| Non-Treponemal Test Result (STD) | 2 , 1 | |
| Null Flavor (HL7 V3) | 1 | |
| Number Of Lesions (VZ) | 2 | |
| Number Of Sex Partners (Hepatitis) | 1 | |
| Number of Cigarettes Smoked per Day (CO) | 1 | |
| Occupation Risk Category (TB) | 1 | |
| Organism (FDD) | 6 , 5 , 4 , 3 , 2 , 1 | |
| Organism Name (Brucellosis) | 1 | |
| Other Related Cases | 1 | |
| Outbreak Type (FDD) | 2 | |
| Oxacillin Interpretation (IPD) | 1 | |
| PCR Specimen Source (CRS) | 2 , 1 | |
| PCR Specimen Source (VZ) | 3 , 2 | |
| Parotitis Laterality (Mumps) | 2 , 1 | |
| Passed Failed Unknown | 1 | |
| Patient Outcome (Listeria) | 1 | |
| Performing Lab Type (Anthrax) | 1 | |
| Performing Lab Type (RIBD) | 1 | |
| Performing Lab Type (Trich) | 1 | |
| Performing Laboratory Type (Leptospirosis) | 1 | |
| Performing Laboratory Type (VPD) | 1 | |
| Person/Organization Taking CO Reading (CO) | 1 | |
| Personal Protective Equipment (RIBD) | 1 | |
| Place of Death (NCHS) | 4 , 3 , 2 | |
| Poison Control Center Record (CO) | 2 , 1 | |
| Pork Type (FDD) | 1 | |
| Positive Negative Unknown | 1 | |
| Positive Negative Unknown Not Done | 1 | |
| Pre-Pregnancy SerologicalTestInterp (CRS) | 2 , 1 | |
| Pregnancy Outcome (FDD) | 2 , 1 | |
| Pregnancy Outcome (Leptospirosis) | 1 | |
| Pregnancy Outcome (Listeria) | 2 , 1 | |
| Pregnancy Status (RIBD) | 2 , 1 | |
| Pregnancy Treatment Stage (NND) | 1 | |
| Pregnancy Trimester | 2 | |
| Prenatal Care Provider (Rubella) | 1 | |
| Present Absent Unknown Not Examined | 1 | |
| Previous Treatment Duration (Hansen) | 1 | |
| Primary Reason For Evaluation (TB) | 3 , 2 , 1 | |
| Procedure Type (Anthrax) | 1 | |
| Public Private Lab | 1 | |
| Public Site of Exposure (CO) | 4 , 3 , 2 | |
| Quantitative Syphilis Test Result (STD) | 3 , 2 , 1 | |
| Race (NCHS) | 2 | |
| Race Category including Null Flavor | 1 | |
| Race Category including Refused | 1 | |
| Race Category including Unknown | 1 | |
| Rash Distribution (VZ) | 1 | |
| Raw Unpasteurized Products (FDD) | 1 | |
| Reason For Test (Hepatitis) | 2 , 1 | |
| Reason Medication Not Completed (BSP) | 1 | |
| Reason Not Treated with RIPE (TB) | 3 | |
| Reason Therapy Stopped (TB) | 3 , 2 , 1 | |
| Reason for Hospitalization (VZ) | 3 , 2 , 1 | |
| Reason for Missing Test (NND) | 1 | |
| Reason for Test (COVID-19) | 1 | |
| Recreational H2O Treatment (FDD) | 2 | |
| Relationship (Hansen) | 1 | |
| Relationship (VPD) | 1 | |
| Reporting Source Type | 2 | |
| Residence Location (RIBD) | 3 , 2 , 1 | |
| Residence Type (COVID-19) | 1 | |
| Residential Site of Exposure (CO) | 3 , 2 , 1 | |
| Respiratory Protective Equipment (RIBD) | 1 | |
| Respondent (Listeria) | 1 | |
| Result of Radiology Study (TB) | 1 | |
| Risk Factor (COVID-19) | 3 , 2 , 1 | |
| Rodent Type (Leptospirosis) | 1 | |
| Route of Administration (STD) | 3 | |
| SPN/IPD Serotype (RIBD) | 2 , 1 | |
| STEC Nonculture Test Type (BIDS) | 1 | |
| School Year (RIBD) | 1 | |
| Seafood Preparation (FDD) | 2 , 1 | |
| Seafood Purchase Info (FDD) | 1 | |
| Seafood Source (FDD) | 1 | |
| Sequelae (Hansen) | 1 | |
| Sequelae (RIBD) | 2 , 1 | |
| Serogroup (NETSS) | 1 | |
| Serogroup Method (RIBD) | 1 | |
| Serotype (Arbovirus) | 1 | |
| Serotype (Dengue) | 1 | |
| Serotype (NETSS) | 1 | |
| Serotype Master (RIBD) | 1 | |
| Serotype Method (IPD) | 1 | |
| Serotype Method (RIBD) | 1 | |
| Setting of Further Spread | 1 | |
| Sexual Contact (FDD) | 1 | |
| Sexual Orientation | 2 , 1 | |
| Sexual Orientation (STD) | 1 | |
| Sexual Orientation (USCDI) | 1 | |
| Sexual Preference (NETSS) | 1 | |
| Shellfish Distributed (FDD) | 1 | |
| Sick Animal Type (Leptospirosis) | 1 | |
| Signs Symptoms (CS) | 1 | |
| Signs and Symptoms (COVID-19) | 2 , 1 | |
| Signs and Symptoms (Listeria) | 1 | |
| Signs and Symptoms (Measles) | 3 | |
| Signs and Symptoms (Mumps) | 3 , 2 | |
| Signs and Symptoms (RIBD) | 2 , 1 | |
| Signs and Symptoms (Rubella) | 3 | |
| Sites of Directly Observed Therapy (TB) | 1 | |
| Skin Exposure (FDD) | 1 | |
| Smoking Status (Anthrax) | 1 | |
| Smoking Status (RIBD) | 1 | |
| Source of Laboratory Test (Hepatitis) | 3 , 2 , 1 | |
| Specimen Collection Setting Type (C. auris) | 2 , 1 | |
| Specimen From Mother Or Infant (CRS) | 2 , 1 | |
| Specimen Source (CP-CRE) | 1 | |
| Specimen Source (CRS) | 2 | |
| Specimen Source (STD) | 2 , 1 | |
| Specimen Source Site (Anthrax) | 1 | |
| Specimen Source Site (Brucellosis) | 1 | |
| Specimen Source Site (Leptospirosis) | 1 | |
| Specimen Source Site (VPD) | 1 | |
| Specimen Type (Anthrax) | 1 | |
| Specimen Type (Brucellosis) | 1 | |
| Specimen Type (Leptospirosis) | 2 , 1 | |
| Specimen Type (RIBD) | 4 , 3 , 2 , 1 | |
| Specimen type (ARLN) | 1 | |
| Specimen type (Trich) | 1 | |
| Sputum Culture Conversion Not Documented Reason | 2 , 1 | |
| States Territories Provinces (NCHS) | 7 , 6 , 5 , 3 , 2 , 1 | |
| Stay Period Hepatitis (NETSS) | 1 | |
| Sterile Specimen (Pediatric Flu) | 1 | |
| Strain Type (Trich) | 3 , 2 , 1 | |
| Strain Type (VZ) | 1 | |
| Substance Abuse (RIBD) | 3 , 2 , 1 | |
| Substance Treatment Refusal Reason | 1 | |
| Susceptibility Data NA (RIBD) | 1 | |
| Susceptibility Interpretation (RIBD) | 3 | |
| Susceptibility Result | 1 | |
| Susceptibility Result (IPD) | 1 | |
| Susceptibility Test Interpretation (TB) | 2 , 1 | |
| Suspected Food Consumed (FDD) | 1 | |
| Swimming Pool Type (FDD) | 1 | |
| Syphilis Clinical Stage (CS) | 1 | |
| Syphilis Neurologic Involvement (STD) | 3 , 2 , 1 | |
| Syphilis Surveillance Stage (CS) | 2 , 1 | |
| Syphilis Treatment Infant (CS) | 1 | |
| Syphilis Treatment Mother (CS) | 1 | |
| Tap Water Source (FDD) | 1 | |
| Tattoo Obtained From (Hepatitis) | 2 , 1 | |
| Test Method (FDD) | 4 , 3 , 2 , 1 | |
| Test Method EIA IgM | 1 | |
| Test Result (FDD) | 3 , 2 , 1 | |
| Test Result (Hepatitis A) | 1 | |
| Test Result (Hepatitis) | 1 | |
| Test Result Coded Qualitative | 1 | |
| Test Results (Brucellosis) | 1 | |
| Test Titer Type (Brucellosis) | 1 | |
| Test Type (Brucellosis) | 2 , 1 | |
| Tetanus Type (VPD) | 1 | |
| Therapy Extended Reason (TB) | 3 , 2 | |
| Time Period Tetanus (NETSS) | 1 | |
| Time Units (NCHS) | 1 | |
| Timing of Maternal Treatment (NND) | 2 , 1 | |
| Titer Test Method (RIBD) | 1 | |
| Titer Test Type (RIBD) | 1 | |
| Total Doses of Vaccine (Anthrax) | 1 | |
| Transmission Setting (NETSS) | 1 | |
| Transmission Setting (NND) | 3 , 2 , 1 | |
| Travel Purpose | 2 | |
| Travel Purpose (CDC) | 1 | |
| Travel Reason (Hepatitis A) | 1 | |
| Travel Reason (Malaria) | 4 , 3 , 2 , 1 | |
| Treatment Location (CO) | 1 | |
| Treatment Outcome Tetanus (VPD) | 1 | |
| Treatment Site (CO) | 2 | |
| Treatment Type (Anthrax) | 1 | |
| Treatment Type (COVID-19) | 2 , 1 | |
| Treponemal Serologic Test (STD) | 2 , 1 | |
| Tribe Name (NND) | 2 , 1 | |
| Type Of Complication (CRS) | 4 , 3 , 2 , 1 | |
| Type Of Complication (Rubella) | 4 | |
| Type of Complication (Measles) | 2 | |
| Type of Complication (STD) | 1 | |
| Type of Correctional Facility | 3 , 2 , 1 | |
| Type of Deafness (Mumps) | 2 , 1 | |
| Type of Long Term Care Facility | 3 , 2 , 1 | |
| Type of Testing at CDC | 2 , 1 | |
| Type of Testing at CDC (NND) | 1 | |
| Type of Testing at CDC (VZ) | 1 | |
| Type of Testing at CDC(Rubella) | 1 | |
| Underlying Condition (RIBD) | 2 , 1 | |
| Underlying Condition(s) (Leptospirosis) | 2 , 1 | |
| Underlying Conditions | 1 | |
| Underlying Conditions (CO) | 3 , 2 | |
| Underlying Conditions (IPD) | 2 | |
| Usual Occupation and Industry (TB) | 2 , 1 | |
| VDRL Test Result (NND) | 1 | |
| VPD Laboratory Coded Observation | 3 , 2 , 1 | |
| VPD Specimen Type | 6 , 5 , 4 | |
| Vaccination Location (CRA) | 1 | |
| Vaccine Doses Received (Pertussis) | 1 | |
| Vaccine Doses Received (Tetanus) | 1 | |
| Vaccine Event Information Source (NND) | 3 , 2 , 1 | |
| Vaccine Exposure (Brucellosis) | 1 | |
| Vaccine Not Given Reason | 3 , 2 , 1 | |
| Vaccine Not Given Reasons (NETSS) | 1 | |
| Vaccines Administered (NETSS) | 1 | |
| Vaccines Administered (VZ) | 2 | |
| Vibrio Biotype (BIDS) | 1 | |
| Vibrio Cholera Biotype (FDD) | 1 | |
| Vibrio Cholera Serotype (FDD) | 1 | |
| Vibrio Cholera Toxin Test Type (BIDS) | 1 | |
| Vibrio Serotype (BIDS) | 1 | |
| Vital Records Education Level (NCHS) | 1 | |
| Water Salinity (FDD) | 1 | |
| Water Source (RIBD) | 1 | |
| Well Water Treatment (FDD) | 1 | |
| Workers Compensation Record (CO) | 2 , 1 | |
| Wound Depth Tetanus (NETSS) | 1 | |
| Wound History | 1 | |
| X-Ray Result (CS) | 1 | |
| YNRD (CDC) | 4 , 3 | |
| Yes No Don't Know Maybe (FDD) | 1 | |
| Yes No Unknown (YNU) | 1 | |
| Yes No Unknown Maybe (FDD) | 1 | |
| Yes No Unknown NA (NND) | 1 | |
| Yes No Unknown No Answer | 1 | |
| Yes No Unknown Not Done | 1 | |
| Yes No Unknown Refused (Listeria) | 1 | |
| Yes No Unknown Refused (NND) | 1 | |